IBDEI2WJ ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,46287,0)
;;=H21.232^^176^2304^29
;;^UTILITY(U,$J,358.3,46287,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46287,1,3,0)
;;=3^Degeneration of Iris,Pigmentary,Left Eye
;;^UTILITY(U,$J,358.3,46287,1,4,0)
;;=4^H21.232
;;^UTILITY(U,$J,358.3,46287,2)
;;=^5005188
;;^UTILITY(U,$J,358.3,46288,0)
;;=H57.00^^176^2304^30
;;^UTILITY(U,$J,358.3,46288,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46288,1,3,0)
;;=3^Anomaly of Pupillary Function,Unspec
;;^UTILITY(U,$J,358.3,46288,1,4,0)
;;=4^H57.00
;;^UTILITY(U,$J,358.3,46288,2)
;;=^5006375
;;^UTILITY(U,$J,358.3,46289,0)
;;=D31.42^^176^2304^31
;;^UTILITY(U,$J,358.3,46289,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46289,1,3,0)
;;=3^Benign Neopl of Ciliary Body,Left Eye
;;^UTILITY(U,$J,358.3,46289,1,4,0)
;;=4^D31.42
;;^UTILITY(U,$J,358.3,46289,2)
;;=^5002125
;;^UTILITY(U,$J,358.3,46290,0)
;;=D31.41^^176^2304^32
;;^UTILITY(U,$J,358.3,46290,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46290,1,3,0)
;;=3^Benign Neopl of Ciliary Body,Right Eye
;;^UTILITY(U,$J,358.3,46290,1,4,0)
;;=4^D31.41
;;^UTILITY(U,$J,358.3,46290,2)
;;=^5002124
;;^UTILITY(U,$J,358.3,46291,0)
;;=C69.41^^176^2304^33
;;^UTILITY(U,$J,358.3,46291,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46291,1,3,0)
;;=3^Malig Neopl of Ciliary Body,Right Eye
;;^UTILITY(U,$J,358.3,46291,1,4,0)
;;=4^C69.41
;;^UTILITY(U,$J,358.3,46291,2)
;;=^5001279
;;^UTILITY(U,$J,358.3,46292,0)
;;=C69.42^^176^2304^34
;;^UTILITY(U,$J,358.3,46292,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46292,1,3,0)
;;=3^Malig Neopl of Ciliary Body,Left Eye
;;^UTILITY(U,$J,358.3,46292,1,4,0)
;;=4^C69.42
;;^UTILITY(U,$J,358.3,46292,2)
;;=^5001280
;;^UTILITY(U,$J,358.3,46293,0)
;;=H35.061^^176^2304^35
;;^UTILITY(U,$J,358.3,46293,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46293,1,3,0)
;;=3^Retinal Vasculitis,Right Eye
;;^UTILITY(U,$J,358.3,46293,1,4,0)
;;=4^H35.061
;;^UTILITY(U,$J,358.3,46293,2)
;;=^5005602
;;^UTILITY(U,$J,358.3,46294,0)
;;=H35.062^^176^2304^36
;;^UTILITY(U,$J,358.3,46294,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46294,1,3,0)
;;=3^Retinal Vasculitis,Left Eye
;;^UTILITY(U,$J,358.3,46294,1,4,0)
;;=4^H35.062
;;^UTILITY(U,$J,358.3,46294,2)
;;=^5005603
;;^UTILITY(U,$J,358.3,46295,0)
;;=H20.011^^176^2304^2
;;^UTILITY(U,$J,358.3,46295,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46295,1,3,0)
;;=3^Iridocyclitis,Primary,Right Eye
;;^UTILITY(U,$J,358.3,46295,1,4,0)
;;=4^H20.011
;;^UTILITY(U,$J,358.3,46295,2)
;;=^5005134
;;^UTILITY(U,$J,358.3,46296,0)
;;=H20.012^^176^2304^3
;;^UTILITY(U,$J,358.3,46296,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46296,1,3,0)
;;=3^Iridocyclitis,Primary,Left Eye
;;^UTILITY(U,$J,358.3,46296,1,4,0)
;;=4^H20.012
;;^UTILITY(U,$J,358.3,46296,2)
;;=^5005135
;;^UTILITY(U,$J,358.3,46297,0)
;;=H20.11^^176^2304^4
;;^UTILITY(U,$J,358.3,46297,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46297,1,3,0)
;;=3^Iridocyclitis,Chronic,Right Eye
;;^UTILITY(U,$J,358.3,46297,1,4,0)
;;=4^H20.11
;;^UTILITY(U,$J,358.3,46297,2)
;;=^5005155
;;^UTILITY(U,$J,358.3,46298,0)
;;=H20.12^^176^2304^5
;;^UTILITY(U,$J,358.3,46298,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46298,1,3,0)
;;=3^Iridocyclitis,Chronic,Left Eye
;;^UTILITY(U,$J,358.3,46298,1,4,0)
;;=4^H20.12
;;^UTILITY(U,$J,358.3,46298,2)
;;=^5005156
;;^UTILITY(U,$J,358.3,46299,0)
;;=H21.551^^176^2304^16
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2WJ 3782 printed Oct 16, 2024@18:37:59 Page 2
IBDEI2WJ ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,46287,0)
+2 ;;=H21.232^^176^2304^29
+3 ;;^UTILITY(U,$J,358.3,46287,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,46287,1,3,0)
+6 ;;=3^Degeneration of Iris,Pigmentary,Left Eye
+7 ;;^UTILITY(U,$J,358.3,46287,1,4,0)
+8 ;;=4^H21.232
+9 ;;^UTILITY(U,$J,358.3,46287,2)
+10 ;;=^5005188
+11 ;;^UTILITY(U,$J,358.3,46288,0)
+12 ;;=H57.00^^176^2304^30
+13 ;;^UTILITY(U,$J,358.3,46288,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,46288,1,3,0)
+16 ;;=3^Anomaly of Pupillary Function,Unspec
+17 ;;^UTILITY(U,$J,358.3,46288,1,4,0)
+18 ;;=4^H57.00
+19 ;;^UTILITY(U,$J,358.3,46288,2)
+20 ;;=^5006375
+21 ;;^UTILITY(U,$J,358.3,46289,0)
+22 ;;=D31.42^^176^2304^31
+23 ;;^UTILITY(U,$J,358.3,46289,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,46289,1,3,0)
+26 ;;=3^Benign Neopl of Ciliary Body,Left Eye
+27 ;;^UTILITY(U,$J,358.3,46289,1,4,0)
+28 ;;=4^D31.42
+29 ;;^UTILITY(U,$J,358.3,46289,2)
+30 ;;=^5002125
+31 ;;^UTILITY(U,$J,358.3,46290,0)
+32 ;;=D31.41^^176^2304^32
+33 ;;^UTILITY(U,$J,358.3,46290,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,46290,1,3,0)
+36 ;;=3^Benign Neopl of Ciliary Body,Right Eye
+37 ;;^UTILITY(U,$J,358.3,46290,1,4,0)
+38 ;;=4^D31.41
+39 ;;^UTILITY(U,$J,358.3,46290,2)
+40 ;;=^5002124
+41 ;;^UTILITY(U,$J,358.3,46291,0)
+42 ;;=C69.41^^176^2304^33
+43 ;;^UTILITY(U,$J,358.3,46291,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,46291,1,3,0)
+46 ;;=3^Malig Neopl of Ciliary Body,Right Eye
+47 ;;^UTILITY(U,$J,358.3,46291,1,4,0)
+48 ;;=4^C69.41
+49 ;;^UTILITY(U,$J,358.3,46291,2)
+50 ;;=^5001279
+51 ;;^UTILITY(U,$J,358.3,46292,0)
+52 ;;=C69.42^^176^2304^34
+53 ;;^UTILITY(U,$J,358.3,46292,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,46292,1,3,0)
+56 ;;=3^Malig Neopl of Ciliary Body,Left Eye
+57 ;;^UTILITY(U,$J,358.3,46292,1,4,0)
+58 ;;=4^C69.42
+59 ;;^UTILITY(U,$J,358.3,46292,2)
+60 ;;=^5001280
+61 ;;^UTILITY(U,$J,358.3,46293,0)
+62 ;;=H35.061^^176^2304^35
+63 ;;^UTILITY(U,$J,358.3,46293,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,46293,1,3,0)
+66 ;;=3^Retinal Vasculitis,Right Eye
+67 ;;^UTILITY(U,$J,358.3,46293,1,4,0)
+68 ;;=4^H35.061
+69 ;;^UTILITY(U,$J,358.3,46293,2)
+70 ;;=^5005602
+71 ;;^UTILITY(U,$J,358.3,46294,0)
+72 ;;=H35.062^^176^2304^36
+73 ;;^UTILITY(U,$J,358.3,46294,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,46294,1,3,0)
+76 ;;=3^Retinal Vasculitis,Left Eye
+77 ;;^UTILITY(U,$J,358.3,46294,1,4,0)
+78 ;;=4^H35.062
+79 ;;^UTILITY(U,$J,358.3,46294,2)
+80 ;;=^5005603
+81 ;;^UTILITY(U,$J,358.3,46295,0)
+82 ;;=H20.011^^176^2304^2
+83 ;;^UTILITY(U,$J,358.3,46295,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,46295,1,3,0)
+86 ;;=3^Iridocyclitis,Primary,Right Eye
+87 ;;^UTILITY(U,$J,358.3,46295,1,4,0)
+88 ;;=4^H20.011
+89 ;;^UTILITY(U,$J,358.3,46295,2)
+90 ;;=^5005134
+91 ;;^UTILITY(U,$J,358.3,46296,0)
+92 ;;=H20.012^^176^2304^3
+93 ;;^UTILITY(U,$J,358.3,46296,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,46296,1,3,0)
+96 ;;=3^Iridocyclitis,Primary,Left Eye
+97 ;;^UTILITY(U,$J,358.3,46296,1,4,0)
+98 ;;=4^H20.012
+99 ;;^UTILITY(U,$J,358.3,46296,2)
+100 ;;=^5005135
+101 ;;^UTILITY(U,$J,358.3,46297,0)
+102 ;;=H20.11^^176^2304^4
+103 ;;^UTILITY(U,$J,358.3,46297,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,46297,1,3,0)
+106 ;;=3^Iridocyclitis,Chronic,Right Eye
+107 ;;^UTILITY(U,$J,358.3,46297,1,4,0)
+108 ;;=4^H20.11
+109 ;;^UTILITY(U,$J,358.3,46297,2)
+110 ;;=^5005155
+111 ;;^UTILITY(U,$J,358.3,46298,0)
+112 ;;=H20.12^^176^2304^5
+113 ;;^UTILITY(U,$J,358.3,46298,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,46298,1,3,0)
+116 ;;=3^Iridocyclitis,Chronic,Left Eye
+117 ;;^UTILITY(U,$J,358.3,46298,1,4,0)
+118 ;;=4^H20.12
+119 ;;^UTILITY(U,$J,358.3,46298,2)
+120 ;;=^5005156
+121 ;;^UTILITY(U,$J,358.3,46299,0)
+122 ;;=H21.551^^176^2304^16
